What's in Shouyao Holdings (Beijing) Co. LTD's pipeline?

Shouyao Holdings (Beijing) Co. LTD has 10 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 6 in Phase 1.

Which companies overlap with Shouyao Holdings (Beijing) Co. LTD's portfolio?

Top competitors by shared drug class: Pfizer, AJU Pharm Co., Ltd., Aciex Therapeutics, Inc., Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shouyao-holdings-beijing-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Shouyao Holdings (Beijing) Co. LTD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shouyao Holdings (Beijing) Co. LTD pipeline: 0 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 1 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Crizotinib Capsules	Crizotinib Capsules	phase 3	ALK/ROS1 tyrosine kinase inhibitor	ALK, ROS1	Oncology
SY-3505 Capsules	SY-3505 Capsules	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
SY-5007	SY-5007	phase 3	SGLT2 inhibitor	SGLT2	Diabetes

Therapeutic area mix

Diabetes · 2
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 2 shared drug classes
AJU Pharm Co., Ltd. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
AO GENERIUM · 1 shared drug class
ADvantage Therapeutics · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shouyao Holdings (Beijing) Co. LTD:

Cite this brief

Drug Landscape (2026). Shouyao Holdings (Beijing) Co. LTD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shouyao-holdings-beijing-co-ltd. Accessed 2026-05-16.